SCLStepan Company
$61.06+29% 1Y
$61.06
$41.3152 weeks$66.21
SCL as reported
Stepan Company reported $2.43B of revenue over the trailing twelve months, +7.6% on the year before. 11 reported series are charted on this page, each one as filed.
$2.43B
Revenue, trailing twelve months · to Q2 2026 · +7.6% against the twelve months before
- Net income
- −$2.7M
Net income · −105% year on year · trailing twelve months to Q2 2026
- Free cash flow
- $37M
Free cash flow · −402% year on year · trailing twelve months to Q2 2026
- Operating margin
- 0.70%
Operating margin · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $2.43B | +7.6% | Q2 2026 |
| Net income | −$2.7M | −105% | Q2 2026 |
| EPS | −$0.12 | −105% | Q2 2026 |
| Gross margin | 12% | n/a | Q2 2026 |
| Operating margin | 0.70% | n/a | Q2 2026 |
| Net margin | −0.19% | n/a | Q2 2026 |
| ROE | 1.5% | n/a | Q2 2026 |
| ROA | 0.78% | n/a | Q2 2026 |
| ROIC | 2.0% | n/a | Q2 2026 |
| Free cash flow | $37M | −402% | Q2 2026 |
| P/E | 22.2 | n/a | Q4 2025 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Stepan Company (SCL) · Revenue and profitRevenue and profitStepan Company (SCL)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
Specialty Chemicals
Ranks #27 of 33 by RyuScore